National Center for Injury Prevention and Control Initial Review Group, (NCIPC IRG), 27156 [E9-13280]

Download as PDF 27156 Federal Register / Vol. 74, No. 108 / Monday, June 8, 2009 / Notices Procedure: Interested persons may present data, information, or views, orally or in writing, on issues pending before the committee. Written submissions may be made to the contact person on or before July 14, 2009. Oral presentations from the public will be scheduled between approximately 1 p.m. to 2 p.m. Those desiring to make formal oral presentations should notify the contact person and submit a brief statement of the general nature of the evidence or arguments they wish to present, the names and addresses of proposed participants, and an indication of the approximate time requested to make their presentation on or before July 6, 2009. Time allotted for each presentation may be limited. If the number of registrants requesting to speak is greater than can be reasonably accommodated during the scheduled open public hearing session, FDA may conduct a lottery to determine the speakers for the scheduled open public hearing session. The contact person will notify interested persons regarding their request to speak by July 7, 2009. Persons attending FDA’s advisory committee meetings are advised that the agency is not responsible for providing access to electrical outlets. FDA welcomes the attendance of the public at its advisory committee meetings and will make every effort to accommodate persons with physical disabilities or special needs. If you require special accommodations due to a disability, please contact Elaine Ferguson at least 7 days in advance of the meeting. FDA is committed to the orderly conduct of its advisory committee meetings. Please visit our Web site at https://www.fda.gov/ AdvisoryCommittees/ AboutAdvisoryCommittees/ ucm111462.htm for procedures on public conduct during advisory committee meetings. Notice of this meeting is given under the Federal Advisory Committee Act (5 U.S.C. app. 2). cprice-sewell on PRODPC61 with NOTICES Dated: May 29, 2009. Randy W. Lutter, Deputy Commissioner for Policy. [FR Doc. E9–13315 Filed 6–5–09; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention National Institutes of Health National Center for Injury Prevention and Control Initial Review Group, (NCIPC IRG) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announce the following meeting of the aforementioned committee: Times and Date: 12:15 p.m.–12:30 p.m., June 30, 2009 (Open) 12:30 p.m.–2:30 p.m., June 30, 2009 (Closed) Place: Teleconference, Toll Free: 888–793– 2154, Participant Passcode: 4424802. Status: Portions of the meetings will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5, U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Section 10(d) of Public Law 92–463. Purpose: This group is charged with providing advice and guidance to the Secretary, Department of Health and Human Services, and the Director, CDC, concerning the scientific and technical merit of grant and cooperative agreement applications received from academic institutions and other public and private profit and nonprofit organizations, including State and local government agencies, to conduct specific injury research that focuses on prevention and control. Matters to be Discussed: The meeting will include the review, discussion, and evaluation of individual research cooperative agreement applications submitted in response to Fiscal Year 2009 Requests for Applications related to the following individual research announcement: RFA– CD–09–001 ‘‘Translating Research to Protect Health through Health Promotion, Prevention, and Preparedness (R18)’’ for the National Center for Environmental Health (NCEH/CDC) applications. Agenda items are subject to change as priorities dictate. Contact Person for More Information: Jane Suen, Dr.P.H., M.S., NCIPC, CDC, 4770 Buford Highway, NE., Mailstop F–62, Atlanta, Georgia 30341. Telephone: (770) 488–4281. The Director, Management Analysis and Services Office has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: May 27, 2009. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E9–13280 Filed 6–5–09; 8:45 am] BILLING CODE 4160–01–S BILLING CODE 4163–18–P VerDate Nov<24>2008 15:15 Jun 05, 2009 Jkt 217001 PO 00000 Frm 00069 Fmt 4703 Sfmt 4703 Center for Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel, Radiation Meeting. Date: June 15, 2009. Time: 11 a.m to 2 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Sally A. Mulhern, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6214, MSC 7804, Bethesda, MD 20892. (301) 435– 5877. mulherns@csr.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: Center for Scientific Review Special Emphasis Panel, Shared Instrumentation Imaging. Date: June 16–17, 2009. Time: 7:30 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Holiday Inn Express Hotel and Suites, San Francisco Fisherman’s Wharf, 550 North Point Street, San Francisco, CA 94133. Contact Person: Dharam S. Dhindsa, DVM, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5110, MSC 7854, Bethesda, MD 20892. (301) 435– 1174. dhindsad@csr.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: Center for Scientific Review Special Emphasis Panel, BMIT/MEDI Member Conflict Review. Date: June 16, 2009. Time: 10:30 a.m. to 3:30 p.m. Agenda: To review and evaluate grant applications. E:\FR\FM\08JNN1.SGM 08JNN1

Agencies

[Federal Register Volume 74, Number 108 (Monday, June 8, 2009)]
[Notices]
[Page 27156]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-13280]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


National Center for Injury Prevention and Control Initial Review 
Group, (NCIPC IRG)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announce the following meeting of the aforementioned 
committee:

    Times and Date: 12:15 p.m.-12:30 p.m., June 30, 2009 (Open)
    12:30 p.m.-2:30 p.m., June 30, 2009 (Closed)
    Place: Teleconference, Toll Free: 888-793-2154, Participant 
Passcode: 4424802.
    Status: Portions of the meetings will be closed to the public in 
accordance with provisions set forth in Section 552b(c)(4) and (6), 
Title 5, U.S.C., and the Determination of the Director, Management 
Analysis and Services Office, CDC, pursuant to Section 10(d) of 
Public Law 92-463.
    Purpose: This group is charged with providing advice and 
guidance to the Secretary, Department of Health and Human Services, 
and the Director, CDC, concerning the scientific and technical merit 
of grant and cooperative agreement applications received from 
academic institutions and other public and private profit and 
nonprofit organizations, including State and local government 
agencies, to conduct specific injury research that focuses on 
prevention and control.
    Matters to be Discussed: The meeting will include the review, 
discussion, and evaluation of individual research cooperative 
agreement applications submitted in response to Fiscal Year 2009 
Requests for Applications related to the following individual 
research announcement: RFA-CD-09-001 ``Translating Research to 
Protect Health through Health Promotion, Prevention, and 
Preparedness (R18)'' for the National Center for Environmental 
Health (NCEH/CDC) applications.
    Agenda items are subject to change as priorities dictate.
    Contact Person for More Information: Jane Suen, Dr.P.H., M.S., 
NCIPC, CDC, 4770 Buford Highway, NE., Mailstop F-62, Atlanta, 
Georgia 30341. Telephone: (770) 488-4281.
    The Director, Management Analysis and Services Office has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities for both CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: May 27, 2009.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. E9-13280 Filed 6-5-09; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.